Ben Shapiro @benshapiro
RT @kerpen: Great news; this is Glaxo and Vir's mAb; 85% effective at preventing hospitalization and death in RCT. https://t.co/YEZPpinSo5 — PolitiTweet.org
The Rational MD @TheRationalMD
Big update on sotrovimab @kerpen! Per a USA Today article, sotrovimab should also come at no cost to the patient. T… https://t.co/i2kakJoBu2